Clinical Trial Update: Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer [Phase 3]

View source ↗

Summary

Phase III clinical trial evaluating Ivonescimab or Bevacizumab in combination with FOLFOX for metastatic colorectal cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• FOLFOX
• Ivonescimab (AK112/SMT112)

Snippet

Sponsor: Summit Therapeutics | Conditions: Metastatic Colorectal Cancer (CRC) | Phase 3 | Status: RECRUITING